Skp2 inhibitor 3
Skp2 inhibitor 3 (E35), an antitumor agent, is a potent S‑Phase Kinase-associated Protein 2 (SKP2) inhibitor, with an IC50 of 4.86 μM for Skp2-Cks1 binding. Skp2 inhibitor 3 (E35) significantly inhibits colony formation and migration, as well as arrests the cell cycle at the S-phase[1].
Product Specifications
UNSPSC
12352101
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/skp2-inhibitor-3.html
Purity
98.07
Solubility
DMSO : 10 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
COC1=CC=C(C2=CC(C)=NC3=NC(SCC4=CC=C(Br)C=C4)=NN32)C(OC)=C1
Molecular Formula
C21H19BrN4O2S
Molecular Weight
471.37
References & Citations
[1]Kaizhao Hu, et al. Discovery of Novel [1,2,4]Triazolo[1,5- a]pyrimidine Derivatives as Novel Potent S-Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer. J Med Chem. 2024 Sep 26;67 (18) :16435-16454.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog